Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

People with Telogen Effluvium often lack vitamin D, ferritin, and zinc.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

Severe COVID-19 increases the risk of hair loss.

General anesthesia might be linked to certain types of hair loss, but more research is needed.

Minoxidil helps hair regrow faster in stress-related hair loss.

Anaphylaxis from cow's milk allergy can cause temporary hair loss in children.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

The food supplement improved hair growth and strength in people with a certain type of hair loss and had no major side effects.

Hair loss after weight loss surgery can improve over time.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

UV rays can cause a type of hair loss known as telogen alopecia.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Heavy metals might contribute to hair loss in Telogen Effluvium.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.